Showing results (1631-1640 of 2,394) with videos related to

Sort By:
Pageof 240
The AAPS Journal|March 30, 2021
Assessment of Drug Delivery Kinetics to Epidermal Targets In VivoM Hoppel, M A M Tabosa, A L Bunge, et al.
The AAPS Journal|March 13, 2015
Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered FlavonoidsPeimin Dai, Lijun Zhu, Feifei Luo, et al.
The AAPS Journal|March 20, 2015
On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced DesignsS Morales-Alcelay, J M de la Torre de Alvarado, A García-Arieta
The AAPS Journal|August 10, 2012
ADME of antibody-maytansinoid conjugatesHans K Erickson, John M Lambert
The AAPS Journal|September 8, 2012
Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRnYang Chen, Joseph P Balthasar
The AAPS Journal|September 8, 2012
Characterising lipid lipolysis and its implication in lipid-based formulation developmentNicky Thomas, René Holm, Thomas Rades, et al.
The AAPS Journal|September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug AdministrationBarbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
The AAPS Journal|April 28, 2023
Long-Acting Injectable Aqueous Suspensions-Summary From an AAPS WorkshopRené Holm, Robert W Lee, Joey Glassco, et al.
The AAPS Journal|August 26, 2020
Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity RiskDilki Wickramarachchi, Gregory Steeno, Zhiping You, et al.
The AAPS Journal|August 18, 2020
A Three-Treatment Two-Stage Design for Selection of a Candidate Formulation and Subsequent Demonstration of BioequivalenceAnders Fuglsang
Pageof 240